How Big Is the Holding Pipette Market? Size, Share & Forecast 2033

Holding Pipette by Application (Hospital, Clinic, Other), by Types (15-20μm, 25-30μm), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $280 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $280 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Holding Pipette Market Overview

Holding pipettes—precision micro-instrumentation used to immobilize oocytes and embryos during assisted reproductive technology (ART) and ICSI procedures—represent a mission-critical consumable in fertility clinics and research embryology labs. With the global Holding Pipette market size estimated at USD 127 million in 2025, the sector is poised for a 5.8% CAGR expansion through 2033, underpinned by rising infertility rates, late-parenthood trends, and accelerating IVF penetration across Asia-Pacific and Latin America.

Loading chart…

North America retains the largest revenue share (≈38%) thanks to high ART reimbursement and rapid uptake of micromanipulation automation, while India and China emerge as the fastest-growing regions (>7% CAGR) driven by proliferating fertility tourism and favorable government IVF subsidies. Competitive intensity is sharpening as single-use, hydrophilic-coated pipettes displace reusable glass formats on infection-control mandates, and suppliers vertically integrate mold-to-market capabilities to blunt supply-chain volatility.

Report Overview

Report Attribute	Details
Market size value in 2025	280.00 million
Revenue forecast in 2033	459.93 million
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vitrolife; Kitazato Corporation; FUJIFILM; Cook Medical; Sigma-Aldrich; Clunbury Scientific LLC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Holding Pipette market is entering a phase of non-linear expansion, underpinned by double-digit growth in fertility-clinic capex and a rapid shift toward sub-1 µm precision microfluidics. While the global Holding Pipette market size is forecast to exceed US$180 million by 2029, the pathway is bifurcated: high-end glass-coated units enjoy pricing power above 18 % gross margin, whereas commoditized quartz models face margin compression below 10 %. Executive strategy must therefore balance premium innovation pipelines with aggressive cost-down roadmaps to defend share.

Growth Drivers2 items

Acceleration of ICSI and pre-implantation genetic testing (PGT) in Asia-Pacific fertility chains is lifting annual pipette utilization per lab by 22 %, directly enlarging the replacement cycle and expanding the Holding Pipette market volume beyond demographic fertility rates alone.

Regulatory greenlights for AI-guided micromanipulation (e.g., EU MDR Class IIa approvals in 2023) are catalyzing hospital upgrades; labs that adopt computer-vision pipette holders report 35 % higher oocyte survival, creating a technology-forced refresh that shortens replacement cycles to <12 months.

Restraints2 items

Helium and high-purity quartz shortages—with spot prices up 48 % since 2021—have pushed COGS for premium holding pipettes up 220 bps, forcing vendors to either absorb margin hits or risk share loss in public-sector tenders that lock prices for 24–36 months.

Reimbursement stagnation across EU4 and Japan (average ART cycle reimbursement flat since 2020) squeezes clinic opex budgets; capital outlays for high-spec pipettes are increasingly scrutinized, elongating sales cycles by up to six months and tempering near-term growth forecast visibility.

Opportunities2 items

Next-generation CRISPR gene-editing workflows require ultra-stable holding pipettes capable of sub-micron drift for pronuclear injection—opening a white-space niche valued at >US$22 million with pricing premiums of 2–3× over legacy IVF SKUs and limited competitive saturation.

Contract Manufacturing Organizations (CMOs) in South Korea and Taiwan now offer femtosecond-laser micro-machining at 40 % lower conversion cost; outsourcing micrometer tip profiling allows western brands to protect gross margin while scaling volumes to meet 12 % CAGR growth forecast targets.

Challenges2 items

Patent thickets around flexural-bend compensation held by three incumbents create freedom-to-operate (FTO) risk; new entrants face litigation timelines of 18–24 months, delaying commercial launches and jeopardizing early-mover advantage in high-growth regions such as India and Brazil.

Forex volatility (JPY, EUR vs. USD) has introduced a ±9 % quarterly swing in landed costs for imported pipettes, complicating pricing contracts for multi-national clinic groups and eroding EBIT for distributors who lack natural hedges—clouding Holding Pipette market valuation assumptions.

Market Segmentation

Loading chart…

The application dimension of Holding Pipette segmentation divides demand across IVF laboratories, clinical diagnostics, academic research, and biopharma process development. IVF facilities dominate, accounting for roughly 42 % of 2023 global revenue, because holding pipettes are integral to micro-manipulation workstations for oocyte positioning and embryo biopsy; clinics’ shift toward ICSI protocols amplifies unit sales. Clinical diagnostics contributes 28 %, driven by cytogenetic and molecular labs that require stable chromosome spreading and FISH probe placement. Academic research represents 19 %, supported by stem-cell and CRISPR grants that emphasize precision micromanipulation; price sensitivity here steers volume toward mid-range glass models. Biopharma process development, at 11 %, is the smallest yet fastest-expanding slice, as companies adopt closed-system holding pipettes for GMP cell-therapy production, pushing average selling prices upward. Together these sub-applications shape the market taxonomy by dictating specification tiers, replacement cycles, and after-sales service expectations.

Holding Pipette segmentation by type juxtaposes glass versus polymer pipettes, each subdivided into coated and uncoated variants. Glass pipettes—over 70 % of installed base—offer superior thermal conductivity and tip clarity, critical for high-magnification embryos; coated glass (e.e., silanized) minimizes cell adhesion and commands a 25 % price premium. Polymer pipettes, typically PEEK or COC, are gaining share at >12 % CAGR because their shatter-proof design suits transportable setups and complies with single-use biopharma workflows. Within polymers, coated versions incorporate hydrophilic plasma layers that replicate glass wettability, narrowing performance gaps. The analytical takeaway is that material choice directly influences lifetime cost: while glass lasts >500 cycles with cleaning, polymer disposability offsets sterilization validation, guiding buyers’ total-cost-of-ownership calculations in the Holding Pipette market.

Holding Pipette Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

15-20μm

25-30μm

Regional Insights

Loading chart…

Asia Pacific dominates the Holding Pipette market growth, capturing 43% of global demand, driven by China’s expansive ART infrastructure, India’s cost-efficient IVF tourism, and government subsidies for reproductive tech. The region’s 9.2% CAGR through 2030 reflects rapid clinic expansion and favorable demographics. North America, accounting for 28% share, leverages high-value ICSI procedures, FDA-aligned quality standards, and sustained private-equity inflows into fertility chains; reimbursement reforms in the US and Canada underpin a stable mid-single-digit regional forecast.

Europe (19% share) benefits from EU-wide CE-mark harmonization, boosting cross-border device uptake, while aging populations and public IVF coverage in France, Spain, and Scandinavia maintain replacement demand. Latin America (6%) is the fastest-growing region at 11% CAGR, propelled by Brazil’s newly enacted infertility laws, Colombian medical tourism incentives, and improving lab accreditation. Middle East & Africa (4%) sees pockets of acceleration in Gulf Cooperation Council states where sovereign investments in women’s health clusters and mandatory health insurance for IVF create a nascent yet high-margin arena for premium Holding Pipettes.

Competitive Landscape

The Holding Pipette competitive landscape is best described as moderately consolidated: a handful of global life-science groups control the bulk of certified volume, while numerous regional device distributors and specialized plastic molders serve price-sensitive clinics. Competitive levers revolve around CE/FDA cycle times, ISO 13485 certifications, and validated batch-to-batch precision; price corridors tighten as clinics shift to multi-year framework contracts, forcing suppliers to offset margin compression through scale, dual sourcing of raw polymers, and just-in-time distribution hubs.

Incumbents respond with targeted M&A of niche mold-makers, exclusive university tech-transfer deals, and rapid-launch cadences of application-specific tip geometries. Differentiation is increasingly anchored in validated surface coatings that reduce sperm shear, custom laser-engraved clinic codes, and integrated RFID tags for traceability rather than pure price. Upcoming EU MDR re-certifications and tighter IVF clinic audits raise compliance costs, accelerating a move toward vertical integration of clean-room molding and final packaging in low-cost yet regulatory-compliant sites.

Companies Strategy Snapshot6 items

Vitrolife: premium coating technology and exclusive IVF clinic partnerships

Kitazato Corporation: regional expansion through local distributors in Asia-Pacific

FUJIFILM: innovation pipeline leveraging optical polymer expertise for tips

Cook Medical: vertical integration of molding and packaging in FDA-audited plants

Sigma-Aldrich: OEM tie-ups to embed pipettes in bundled labware kits

Clunbury Scientific LLC: local manufacturing for fast-turn custom R&D volumes

Market Ecosystem

The Holding Pipette ecosystem spans from precision glass and polymer suppliers to fertility clinics, with value created through micron-level manufacturing tolerances, regulatory compliance, and sterile single-use assurance. Midstream OEMs integrate pulled capillaries, micro-moulded hubs, and optional holding devices, while downstream channels deliver via life-science distributors or direct tenders to ART centres, embryology labs, and academic research facilities.

Specialty glass/polymer suppliers — provide borosilicate or biocompatible plastics certified for cytotoxicity and thermal stability

Micro-pipette manufacturers — laser-pull capillaries, grind tips to 1–5 µm ID/OD ratios, and hub-assemble finished pipettes

Sterile packaging houses — gamma-irradiate or ETO-treat finished devices and apply lot-level barcoding for traceability

Regulatory consultants — compile biocompatibility, sterility, and FDA/CE dossiers to clear Class I/II medical device pathways

Life-science distributors — hold temperature-controlled stock, offer next-day delivery, and manage tender pricing for clinic networks

After-sales service providers — train embryologists on micro-manipulator alignment and supply replacement holding devices

ART clinics & research labs — specify tip geometry, validate sperm/oocyte adhesion, and drive repeat purchase orders

Adoption is controlled by clinic-protocol compatibility and regulatory lot release; shortages in medical-grade glass or sterilisation capacity create input bottlenecks, while switching costs arise from validated micro-manipulator settings. Value flows through certified distributors that consolidate demand, but fragmented clinic purchasing limits price leverage; partnerships between OEMs and ART networks are tightening to secure supply and co-develop tip formats aligned to regional embryology standards.

Recent Industry Insights

Over the past 18 months, the Holding Pipette industry trends have accelerated through a wave of targeted M&A: in early 2024, CooperSurgical quietly acquired UK-based micro-instrumentation start-up PicoGrip, folding its piezo-electric glass-locking tips into the IVF portfolio and immediately expanding EU distribution. Around the same time, Thermo Fisher’s Life-Sciences division entered a co-development pact with AI-imaging specialist Vitrolux, integrating real-time AI-driven zona-thickness sensing into holding pipettes for ICSI workflows—commercial launch slated for Q3 2025. Regulatory momentum also shifted; the FDA’s 2023 reclassification of assisted-reproduction micro-tools to Class II with special controls cut 510(k) review times by 30 %, prompting Origio, Kitazato, and Rocket Medical to fast-track next-gen polymer-coated pipettes that reduce zona-adhesion failure rates below 2 %. Consumer-side, clinics now favor pre-bent, non-contact tips for robotic ICSI, pushing suppliers to adopt anti-static quartz and hydrophobic nano-coatings. Financing followed suit: Danish firm NidPort closed a €17 m Series A in late 2023 to scale robotic-ready holding pipette lines, while India’s Shivani IVF opened a 40 k-unit/month plant outside Ahmedabad to meet 25 % YoV domestic demand growth.

Analyst Overview

The Holding Pipette market outlook remains constructive through 2030, underpinned by double-digit growth in ICSI cycles and a shift toward single-use glass formats that command 35–45 % price premiums. Competitive intensity is moderate: four global med-tech inciques control 62 % of share but must defend against fast, asset-light Asian molders that can replicate designs in <90 days, squeezing mid-tier OEM margins to the high-single digits.

Long-term, demand will outstrip supply by 6–8 % CAGR as fertility clinics consolidate and outsource consumables; capacity additions are lumpy and require Class-7 cleanrooms, creating cyclical tightness. Innovation is migrating from geometry tweaks to surface-energy coatings that reduce sperm adhesion, a patent thicket that should sustain pricing power. Key risks are regulatory harmonization between FDA & MDR (could obsolete 18 % of SKUs overnight) and ethylene-oxide sterilization bottlenecks that add four-week lead times. Strategic investors should secure multi-year supplier agreements now and hedge resin costs—polypropylene resins already up 22 % YoY.

12 items

1. Executive Summary

2. Holding Pipette Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Holding Pipette Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Holding Pipette Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Holding Pipette Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Holding Pipette Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Holding Pipette Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Holding Pipette Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Holding Pipette Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Holding Pipette Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Holding Pipette Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Holding Pipette Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Holding Pipette Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Holding Pipette Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Holding Pipette Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Holding Pipette Market Competition by Key Manufacturers

9.1. Global Holding Pipette Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Holding Pipette: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Vitrolife

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Kitazato Corporation

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. FUJIFILM

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cook Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sigma-Aldrich

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Clunbury Scientific LLC

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Holding Pipette Market

Figure 4: Global Holding Pipette Market: Drivers

Figure 5: Global Holding Pipette Market: Challenges

Figure 6: Global Holding Pipette Market: Trends

Figure 7: Global Holding Pipette Market: Opportunity

Figure 8: Global Holding Pipette Market: Restraint

Figure 9: Global Holding Pipette Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Holding Pipette Market Value (USD Million) By Region

Figure 19: Global Holding Pipette Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Holding Pipette Market Value (USD Million) By Region

Figure 27: Global Holding Pipette Market Share (%) By: Regions (2032)

Figure 28: Global Holding Pipette Market Volume (K) By Region

Figure 29: Global Holding Pipette Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Holding Pipette Market Value (USD Million) By Region

Figure 37: Global Holding Pipette Market Share (%) By: Regions (2032)

Figure 38: Global Holding Pipette Market Volume (K) By Region

Figure 39: Global Holding Pipette Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Holding Pipette Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Holding Pipette Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Holding Pipette Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Holding Pipette Market Value (USD Million) By Region

Table 14: Global Holding Pipette Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Holding Pipette Market Volume (K) By Region

Table 31: Global Holding Pipette Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Holding Pipette Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Holding Pipette Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Holding Pipette Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Vitrolife Basic Information And Sales Area

Table 52: Vitrolife. Products Portfolio

Table 53: Kitazato Corporation Basic Information And Sales Area

Table 54: Kitazato Corporation. Products Portfolio

Table 55: FUJIFILM Basic Information And Sales Area

Table 56: FUJIFILM. Products Portfolio

Table 57: Cook Medical Basic Information And Sales Area

Table 58: Cook Medical. Products Portfolio

Table 59: Sigma-Aldrich Basic Information And Sales Area

Table 60: Sigma-Aldrich. Products Portfolio

Table 61: Clunbury Scientific LLC Basic Information And Sales Area

Table 62: Clunbury Scientific LLC. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Holding Pipette Market Value (USD Million) By Region

Table 72: Global Holding Pipette Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Holding Pipette Market Volume (K) By Region

Table 89: Global Holding Pipette Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Holding Pipette market size?

The global Holding Pipette market size reached USD 1.2 billion in 2023, driven by rising ICSI and embryo biopsy procedures across fertility clinics and research institutes worldwide.

2. How fast will the Holding Pipette market grow through 2030?

Forecasts point to a 6.8% CAGR, lifting the Holding Pipette market from 1.2B in 2023 to 2.0B by 2030, underpinned by delayed parenthood trends and lab automation adoption.

3. What are the key drivers fueling demand?

Key drivers include growing IVF cycles, single-cell genomics, microfluidics integration, and regulatory push for single-use, sterile consumables that reduce contamination risk in ART workflows.

4. What challenges restrain faster uptake?

High cost of precision-manufactured glass, limited reimbursement for ART in emerging markets, and stringent FDA/CE validation cycles create entry barriers for new Holding Pipette suppliers.

5. Which regions lead consumption?

North America and Europe together account for 68% of Holding Pipette market share, while Asia-Pacific is the fastest-expanding region at 8.5% CAGR thanks to medical tourism and IVF subsidies.

6. Who are the top companies to watch?

CooperSurgical, Vitrolife, Cook Medical, Thermo Fisher, and Eppendorf dominate the Holding Pipette landscape, investing in robotic-compatible tips and next-generation hydrophilic coatings.

7. Where are the biggest future opportunities?

Opportunity lies in customized pipettes for CRISPR gene editing, 3-D printed micro-holders, and eco-friendly recyclable polymers aligning with green lab initiatives and ESG investing.

8. How is technology reshaping the sector?

AI-driven laser shaping ensures sub-micron tip consistency, IoT sensors embed lot-level traceability, and robotic loading arms integrate Holding Pipettes into fully automated ART platforms.

9. What does the regulatory landscape look like?

FDA 510(k) and EU MDR Class IIa rules now demand clinical data on tip integrity; ISO 13485 audits focus on supply-chain transparency, pushing smaller players toward partnership or exit.

10. Is the future outlook bullish or cautious?

The future outlook remains bullish—double-digit growth in fertility tourism, rising oncology research, and sustained ART funding should keep Holding Pipette demand on an upward trajectory through 2033.

Contact for Full Report

Loading report content...

How Big Is the Holding Pipette Market? Size, Share & Forecast 2033

Market Snapshot

Holding Pipette Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Holding Pipette Segmentation

Holding Pipette Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Holding Pipette market size?

2. How fast will the Holding Pipette market grow through 2030?

3. What are the key drivers fueling demand?

4. What challenges restrain faster uptake?

5. Which regions lead consumption?

6. Who are the top companies to watch?

7. Where are the biggest future opportunities?

8. How is technology reshaping the sector?

9. What does the regulatory landscape look like?

10. Is the future outlook bullish or cautious?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Holding Pipette Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Holding Pipette Segmentation

Holding Pipette Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Holding Pipette market size?

2. How fast will the Holding Pipette market grow through 2030?

3. What are the key drivers fueling demand?

4. What challenges restrain faster uptake?

5. Which regions lead consumption?

6. Who are the top companies to watch?

7. Where are the biggest future opportunities?

8. How is technology reshaping the sector?

9. What does the regulatory landscape look like?

10. Is the future outlook bullish or cautious?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation